Journal of Clinical Endocrinology & Metabolism, Vol 66, 626-631, Copyright © 1988 by Endocrine Society

ARTICLES

Endogenous dopamine (DA) and DA2 receptors: a mechanism limiting excessive sympathetic-adrenal discharge in humans

M Mannelli, C Pupilli, G Fabbri, R Musante, ML De Feo, F Franchi and G Giusti
Endocrinology Service USL 10/D, Florence, Italy.

We studied the effects of presynaptic dopamine (DA) 2 receptor blockade on the sympathetic-adrenal response to graded exercise in seven normal men. DA2 receptor blockade was achieved by means of domperidone (DMP) administration. The exercise consisted of progressive cycling activity, from 30-80% of the predetermined maximal oxygen consumption for each man. Systolic, diastolic, and mean arterial pressures; heart rate; and plasma norepinephrine (NE), epinephrine (E), PRL, glucose, lactate, FFA, sodium, potassium, cortisol, and PRA were measured at rest, during exercise, and during recovery after placebo or DMP administration. Graded exercise caused significant increases in systolic and mean arterial pressures and plasma NE, E, lactate, sodium, potassium, FFA, cortisol, and PRA. DMP administration before exercise caused a significant increase in plasma PRL (P = 0.0009), a greater increase in plasma NE at the end of the exercise (P = 0.002), and an overall increase in plasma E (P = 0.02) and FFA (P = 0.02) concentrations. These results strongly suggest that endogenous DA limits catecholamine release during sympathetic-adrenal stimulation by activating DA2 receptors.

This article has been cited by other articles:

				R. Pivonello, D. Ferone, G. Lombardi, A. Colao, S. W J Lamberts, and L. J Hofland Novel insights in dopamine receptor physiology Eur. J. Endocrinol., April 1, 2007; 156(suppl_1): S13 - S21. [Abstract] [Full Text] [PDF]

				R. Pivonello, D. Ferone, W. W. de Herder, R. R. de Krijger, M. Waaijers, D. M. Mooij, P. M. van Koetsveld, A. Barreca, M. L. Del Basso De Caro, G. Lombardi, et al. Dopamine Receptor Expression and Function in Human Normal Adrenal Gland and Adrenal Tumors J. Clin. Endocrinol. Metab., September 1, 2004; 89(9): 4493 - 4502. [Abstract] [Full Text] [PDF]

				K.-D. Wu, Y.-M. Chen, T.-S. Chu, S.-C. Chueh, M.-H. Wu, and H. Bor-Shen Expression and Localization of Human Dopamine D2 and D4 Receptor mRNA in the Adrenal Gland, Aldosterone-Producing Adenoma, and Pheochromocytoma J. Clin. Endocrinol. Metab., September 1, 2001; 86(9): 4460 - 4467. [Abstract] [Full Text] [PDF]

				F. Franchi, C. Lazzeri, G. Barletta, L. Ianni, and M. Mannelli Centrally Mediated Effects of Bromocriptine on Cardiac Sympathovagal Balance Hypertension, July 1, 2001; 38(1): 123 - 129. [Abstract] [Full Text] [PDF]

				M. Mannelli, L. Ianni, C. Lazzeri, W. Castellani, C. Pupilli, G. La Villa, G. Barletta, M. Serio, and F. Franchi In Vivo Evidence That Endogenous Dopamine Modulates Sympathetic Activity in Man Hypertension, September 1, 1999; 34(3): 398 - 402. [Abstract] [Full Text] [PDF]

				C. MISSALE, S. R. NASH, S. W. ROBINSON, M. JABER, and M. G. CARON Dopamine Receptors: From Structure to Function Physiol Rev, January 1, 1998; 78(1): 189 - 225. [Abstract] [Full Text] [PDF]